Literature DB >> 24769661

Wide complex ventricular tachycardia presenting sign of metastatic pleural mesothelioma.

Ashmeet Bhatia1, Tokunbo Ajayi.   

Abstract

Malignant mesothelioma is an uncommon neoplasm of serosal surfaces, such as the pleura, the peritoneum, less frequently pericardium and tunica vaginalis. It usually spreads locally to the lungs and mediastinum. We describe a case of malignant mesothelioma with metastasis to the heart. The patient presented with syncope, chest pain and light-headedness. He was found to have wide complex ventricular tachycardia (Vtach). He was cardioverted and then noted to have multiple (more than 20) similar episodes during the hospital course. He was treated with multiple antiarrhythmic medications. A CT scan of the chest revealed a circumferential rind of soft tissue in the right hemithorax and invasion of the pericardium. The repeated Vtach episodes were secondary to the metastasis of the pericardium. Oncology was involved and as there were no further treatment options available, the patient was discharged home with hospice care. The disease is a huge economic burden and early recognition can lead to better outcomes.

Entities:  

Mesh:

Year:  2014        PMID: 24769661      PMCID: PMC4009837          DOI: 10.1136/bcr-2013-200654

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  7 in total

1.  A proposed new international TNM staging system for malignant pleural mesothelioma from the International Mesothelioma Interest Group.

Authors:  V W Rusch
Journal:  Lung Cancer       Date:  1996-02       Impact factor: 5.705

Review 2.  Advances in malignant mesothelioma.

Authors:  Bruce W S Robinson; Richard A Lake
Journal:  N Engl J Med       Date:  2005-10-13       Impact factor: 91.245

3.  Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.

Authors:  Nicholas J Vogelzang; James J Rusthoven; James Symanowski; Claude Denham; E Kaukel; Pierre Ruffie; Ulrich Gatzemeier; Michael Boyer; Salih Emri; Christian Manegold; Clet Niyikiza; Paolo Paoletti
Journal:  J Clin Oncol       Date:  2003-07-15       Impact factor: 44.544

4.  Miliary spread of malignant pleural mesothelioma without a clinically identifiable pleural tumour.

Authors:  A W Musk; J Dewar; K B Shilkin; D Whitaker
Journal:  Aust N Z J Med       Date:  1991-08

5.  SV40 in human tumors: new documents shed light on the apparent controversy.

Authors:  Donald S MacLachlan
Journal:  Anticancer Res       Date:  2002 Nov-Dec       Impact factor: 2.480

6.  Cardiac abnormalities in patients with diffuse malignant pleural mesothelioma.

Authors:  S Wadler; P Chahinian; W Slater; M Goldman; D Mendelson; J F Holland
Journal:  Cancer       Date:  1986-12-15       Impact factor: 6.860

7.  Promising early local control of malignant pleural mesothelioma following postoperative intensity modulated radiotherapy (IMRT) to the chest.

Authors:  Anesa Ahamad; Craig W Stevens; W Roy Smythe; Zhongxing Liao; Ara A Vaporciyan; David Rice; Garrett Walsh; Thomas Guerrero; Joe Chang; Brent Bell; Ritsuko Komaki; Kenneth M Forster
Journal:  Cancer J       Date:  2003 Nov-Dec       Impact factor: 3.360

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.